In addition, it has also been reported that OPA1-mediated suppression of cytochrome c release is linked to venetoclax resistance in acute myeloid leukemia (AML), which is an example of acquired drug resistance [118]. The gene discussed is OPA1; the disease is acute myeloid leukemia.